{"product_id":"drug-safety-managing-innovation-in-rheumatology-an-issue-of-rheumatic-disease-clinics-volume-38-4-the-clinics-internal-medicine-volume-38-4","title":"Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics (Volume 38-4) (The Clinics: Internal Medicine, Volume 38-4)","description":"\u003cp\u003e\u003cstrong\u003eBook info:\u003c\/strong\u003e Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics (Volume 38-4) (The Clinics: Internal Medicine, Volume 38-4) (Hardcover, 240 pages) – Saunders, 2012. Language: English.\u003c\/p\u003e\n Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.  ","brand":"John J Cush, Kathryn H. Dao","offers":[{"title":"Default Title","offer_id":46070037348586,"sku":"9781455750658","price":82.47,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0714\/5301\/6298\/files\/41OpyY-ziYL._SL1500.jpg?v=1781239173","url":"https:\/\/textbookme.store\/products\/drug-safety-managing-innovation-in-rheumatology-an-issue-of-rheumatic-disease-clinics-volume-38-4-the-clinics-internal-medicine-volume-38-4","provider":"TextbookMe","version":"1.0","type":"link"}